Seres Therapeutics Inc (MCRB) Stock Analysis

Seres Therapeutics Inc (MCRB) is a publicly traded company in the HEALTHCARE sector. It trades at $7.33, carries a market capitalization of $73.98M. This page summarizes the public market data, fundamentals, and frequently asked questions for MCRB, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $7.33
• Market Cap: $73.98M
• EPS: $-5.20
• 52-Week High: $29.98
• 52-Week Low: $6.56

Market Sentiment

Seres Therapeutics Inc currently has a Neutral sentiment score of 0.02.

About Seres Therapeutics Inc

Seres Therapeutics, Inc. (MCRB) is a pioneering microbiome therapeutic platform company based in Cambridge, Massachusetts, focused on developing innovative bacterial consortia to address a variety of diseases, including Clostridioides difficile infections and inflammatory bowel disease. The company leverages its extensive expertise in microbiome science to create transformative therapies designed to restore microbiome balance and improve patient outcomes. With a robust pipeline and a strong c...

GNG Research Analysis

GNG Research scores Seres Therapeutics Inc (MCRB) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for MCRB.

Frequently Asked Questions

Does MCRB pay dividends?

Seres Therapeutics Inc (MCRB) does not currently pay a regular dividend.

What is MCRB's market cap?

Seres Therapeutics Inc (MCRB) has a market capitalization of $73.98M with a current stock price of $7.33.